Literature DB >> 8917548

Pleiotropic defects in ataxia-telangiectasia protein-deficient mice.

A Elson1, Y Wang, C J Daugherty, C C Morton, F Zhou, J Campos-Torres, P Leder.   

Abstract

We have generated a mouse model for ataxia-telangiectasia by using gene targeting to generate mice that do not express the Atm protein. Atm-deficient mice are retarded in growth, do not produce mature sperm, and exhibit severe defects in T cell maturation while going on to develop thymomas. Atm-deficient fibroblasts grow poorly in culture and display a high level of double-stranded chromosome breaks. Atm-deficient thymocytes undergo spontaneous apoptosis in vitro significantly more than controls. Atm-deficient mice then exhibit many of the same symptoms found in ataxia-telangiectasia patients and in cells derived from them. Furthermore, we demonstrate that the Atm protein exists as two discrete molecular species, and that loss of one or of both of these can lead to the development of the disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917548      PMCID: PMC24050          DOI: 10.1073/pnas.93.23.13084

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  Ataxia-telangiectasia: closer to unraveling the mystery.

Authors:  Y Shiloh
Journal:  Eur J Hum Genet       Date:  1995       Impact factor: 4.246

2.  Influence of ataxia telangiectasia gene dosage on bleomycin-induced chromosome breakage and inhibition of replication in human lymphoblastoid cell lines.

Authors:  P H Kohn; K H Kraemer; J K Buchanan
Journal:  Exp Cell Res       Date:  1982-02       Impact factor: 3.905

3.  Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia.

Authors:  P J Byrd; C M McConville; P Cooper; J Parkhill; T Stankovic; G M McGuire; J A Thick; A M Taylor
Journal:  Hum Mol Genet       Date:  1996-01       Impact factor: 6.150

4.  Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia.

Authors:  M Carbonari; M Cherchi; R Paganelli; G Giannini; E Galli; C Gaetano; C Papetti; M Fiorilli
Journal:  N Engl J Med       Date:  1990-01-11       Impact factor: 91.245

5.  Identification and chromosomal localization of Atm, the mouse homolog of the ataxia-telangiectasia gene.

Authors:  I Pecker; K B Avraham; D J Gilbert; K Savitsky; G Rotman; R Harnik; T Fukao; E Schröck; S Hirotsune; D A Tagle; F S Collins; A Wynshaw-Boris; T Ried; N G Copeland; N A Jenkins; Y Shiloh; Y Ziv
Journal:  Genomics       Date:  1996-07-01       Impact factor: 5.736

Review 6.  Leukemia and lymphoma in ataxia telangiectasia.

Authors:  A M Taylor; J A Metcalfe; J Thick; Y F Mak
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

Review 7.  Cancer risks in A-T heterozygotes.

Authors:  D F Easton
Journal:  Int J Radiat Biol       Date:  1994-12       Impact factor: 2.694

8.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

Authors:  K Savitsky; A Bar-Shira; S Gilad; G Rotman; Y Ziv; L Vanagaite; D A Tagle; S Smith; T Uziel; S Sfez; M Ashkenazi; I Pecker; M Frydman; R Harnik; S R Patanjali; A Simmons; G A Clines; A Sartiel; R A Gatti; L Chessa; O Sanal; M F Lavin; N G Jaspers; A M Taylor; C F Arlett; T Miki; S M Weissman; M Lovett; F S Collins; Y Shiloh
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

9.  Breast and other cancers in families with ataxia-telangiectasia.

Authors:  M Swift; P J Reitnauer; D Morrell; C L Chase
Journal:  N Engl J Med       Date:  1987-05-21       Impact factor: 91.245

10.  Predominance of null mutations in ataxia-telangiectasia.

Authors:  S Gilad; R Khosravi; D Shkedy; T Uziel; Y Ziv; K Savitsky; G Rotman; S Smith; L Chessa; T J Jorgensen; R Harnik; M Frydman; O Sanal; S Portnoi; Z Goldwicz; N G Jaspers; R A Gatti; G Lenoir; M F Lavin; K Tatsumi; R D Wegner; Y Shiloh; A Bar-Shira
Journal:  Hum Mol Genet       Date:  1996-04       Impact factor: 6.150

View more
  166 in total

1.  Spontaneous and oxidative stress-induced programmed cell death in lymphocytes from patients with ataxia telangiectasia (AT).

Authors:  R Schubert; J Reichenbach; N Royer; M Pichler; S Zielen
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

2.  Genomic instability in mice lacking histone H2AX.

Authors:  Arkady Celeste; Simone Petersen; Peter J Romanienko; Oscar Fernandez-Capetillo; Hua Tang Chen; Olga A Sedelnikova; Bernardo Reina-San-Martin; Vincenzo Coppola; Eric Meffre; Michael J Difilippantonio; Christophe Redon; Duane R Pilch; Alexandru Olaru; Michael Eckhaus; R Daniel Camerini-Otero; Lino Tessarollo; Ferenc Livak; Katia Manova; William M Bonner; Michel C Nussenzweig; André Nussenzweig
Journal:  Science       Date:  2002-04-04       Impact factor: 47.728

3.  The controlling role of ATM in homologous recombinational repair of DNA damage.

Authors:  C Morrison; E Sonoda; N Takao; A Shinohara; K Yamamoto; S Takeda
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

Review 4.  A peek into the complex realm of histone phosphorylation.

Authors:  Taraswi Banerjee; Debabrata Chakravarti
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

5.  Integrated signaling in developing lymphocytes: the role of DNA damage responses.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

6.  T-cell-specific deletion of Mof blocks their differentiation and results in genomic instability in mice.

Authors:  Arun Gupta; Clayton R Hunt; Raj K Pandita; Juhee Pae; K Komal; Mayank Singh; Jerry W Shay; Rakesh Kumar; Kiyoshi Ariizumi; Nobuo Horikoshi; Walter N Hittelman; Chandan Guha; Thomas Ludwig; Tej K Pandita
Journal:  Mutagenesis       Date:  2013-02-05       Impact factor: 3.000

7.  p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice.

Authors:  Irene M Ward; Kay Minn; Jan van Deursen; Junjie Chen
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  RADIOSENSITIVITY TO HIGH ENERGY IRON IONS IS INFLUENCED BY HETEROZYGOSITY for ATM, RAD9 and BRCA1.

Authors:  G Zhou; L B Smilenov; H B Lieberman; T Ludwig; E J Hall
Journal:  Adv Space Res       Date:  2010-09-01       Impact factor: 2.152

9.  HUS1 regulates in vivo responses to genotoxic chemotherapies.

Authors:  G Balmus; P X Lim; A Oswald; K R Hume; A Cassano; J Pierre; A Hill; W Huang; A August; T Stokol; T Southard; R S Weiss
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

10.  Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.

Authors:  Lori A Ehrlich; Katherine Yang-Iott; Craig H Bassing
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.